advertisement
Xia X 13
Showing records 1 to 13 | Display all abstracts from Xia X123554 Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptide
Zhu Y
Experimental Eye Research 2024; 246: 110017
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Zhou X; Rong R
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
123554 Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptide
Nair RV; Xia X
Experimental Eye Research 2024; 246: 110017
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Liang G; Wu Y
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
123554 Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptide
Nahmou M
Experimental Eye Research 2024; 246: 110017
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Xu C
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
123554 Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptide
Li X
Experimental Eye Research 2024; 246: 110017
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Xiao H
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
123554 Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptide
Yan W; Li J
Experimental Eye Research 2024; 246: 110017
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Ji D
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
123554 Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptide
Tanasa B
Experimental Eye Research 2024; 246: 110017
120382 Self-Assembly Hypoxic and ROS Dual Response Nano Prodrug as a New Therapeutic Approach for Glaucoma Treatments
Xia X
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024; 11: e2407043
123554 Reversal of injury-associated retinal ganglion cell gene expression by a phosphodiesterase anchoring disruptor peptide
Goldberg JL; Kapiloff MS
Experimental Eye Research 2024; 246: 110017